Table 2.
Baseline Characteristics
N = 20 | |
Age | 52 (24–73) |
Sex | 10M/10F |
Performance Status | 2 (1–3) |
Diagnosis: | |
AML | 15 |
ALL | 3 |
Biphenotypic | 2 |
Number of prior regimens | 3 (1–5) |
Prior stem cell transplant | 3 (1 auto/2 allo) |
Prior AHD | 6 (5 MDS/1 aplastic anemia) |
Cytogenetics: | |
Good Risk | 2 (10%) |
Intermediate Risk | 13 (65%) |
High Risk | 5 (25%) |